Identifying Repurposable Drugs for Schizophrenia using Transcriptomic Datasets

Authors

  • Roshan Sirole Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH Author https://orcid.org/0009-0000-9615-3666
  • Ali Imami Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH Author
  • Robert McCullumsmith Department of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH Author

DOI:

https://doi.org/10.46570/utjms-2025-1521

Keywords:

Neuroscience, Schizophrenia, SCZ, Treatment-resistant schizophrenia, Gene dysregulation, Drug repurposing

Downloads

Published

2025-10-15

Issue

Vol. 14 No. S1 (2025): 2025 Department of Neurosciences and Psychiatry Symposium

Section

Departments of Neuroscience and Psychiatry Research Symposium

License

Copyright (c) 2025 Roshan Sirole, Ali Imami, Robert McCullumsmith (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Identifying Repurposable Drugs for Schizophrenia using Transcriptomic Datasets. Translation. 2025;14(S1). doi:10.46570/utjms-2025-1521